azetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone

C105H125F11N38O8 — CID 159678068

IUPACazetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone
SMILESCCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(N[C@H]3CCN(C(=O)C4CC(OC)C4)C3)ncnc21.CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(N[C@H]3CCN(C(=O)C4CCCC4)C3)ncnc21.CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(N[C@H]3CCN(C(=O)N4CCC4)C3)ncnc21.CCn1c(-c2cnc(C)nc2)nc2c(N[C@H]3CCN(C(=O)N4CC(OC)C4)C3)ncnc21.CCn1c(C(F)F)nc2c(N[C@H]3CCN(C(=O)N4CC(OC)C4)C3)ncnc21
InChIInChI=1S/C23H26F3N7O2.C23H26F3N7O.C21H23F3N8O.C21H27N9O2.C17H23F2N7O2/c1-3-33-20(13-4-5-17(27-10-13)23(24,25)26)31-18-19(28-12-29-21(18)33)30-15-6-7-32(11-15)22(34)14-8-16(9-14)35-2;1-2-33-20(15-7-8-17(27-11-15)23(24,25)26)31-18-19(28-13-29-21(18)33)30-16-9-10-32(12-16)22(34)14-5-3-4-6-14;1-2-32-18(13-4-5-15(25-10-13)21(22,23)24)29-16-17(26-12-27-19(16)32)28-14-6-9-31(11-14)20(33)30-7-3-8-30;1-4-30-19(14-7-22-13(2)23-8-14)27-17-18(24-12-25-20(17)30)26-15-5-6-28(9-15)21(31)29-10-16(11-29)32-3;1-3-26-15-12(23-16(26)13(18)19)14(20-9-21-15)22-10-4-5-24(6-10)17(27)25-7-11(8-25)28-2/h4-5,10,12,14-16H,3,6-9,11H2,1-2H3,(H,28,29,30);7-8,11,13-14,16H,2-6,9-10,12H2,1H3,(H,28,29,30);4-5,10,12,14H,2-3,6-9,11H2,1H3,(H,26,27,28);7-8,12,15-16H,4-6,9-11H2,1-3H3,(H,24,25,26);9-11,13H,3-8H2,1-2H3,(H,20,21,22)/t14?,15-,16?;16-;14-;15-;10-/m00000/s1
InChIKeyMUWBZJNQCPMXTR-KFOHKXHASA-N
MW2256.39 g/mol
LogP14.00
Rot. Bonds25

About azetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone

azetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone (PubChem CID 159678068) has the molecular formula C105H125F11N38O8 and a molecular weight of 2256.39 g/mol. Its IUPAC name is azetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone.

Molecular Properties

Compound Nameazetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone
PubChem CID159678068
Molecular FormulaC105H125F11N38O8
Molecular Weight2256.39 g/mol
Exact Mass2255.04
IUPAC Nameazetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone
SMILESCCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(N[C@H]3CCN(C(=O)C4CC(OC)C4)C3)ncnc21.CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(N[C@H]3CCN(C(=O)C4CCCC4)C3)ncnc21.CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(N[C@H]3CCN(C(=O)N4CCC4)C3)ncnc21.CCn1c(-c2cnc(C)nc2)nc2c(N[C@H]3CCN(C(=O)N4CC(OC)C4)C3)ncnc21.CCn1c(C(F)F)nc2c(N[C@H]3CCN(C(=O)N4CC(OC)C4)C3)ncnc21
InChIInChI=1S/C23H26F3N7O2.C23H26F3N7O.C21H23F3N8O.C21H27N9O2.C17H23F2N7O2/c1-3-33-20(13-4-5-17(27-10-13)23(24,25)26)31-18-19(28-12-29-21(18)33)30-15-6-7-32(11-15)22(34)14-8-16(9-14)35-2;1-2-33-20(15-7-8-17(27-11-15)23(24,25)26)31-18-19(28-13-29-21(18)33)30-16-9-10-32(12-16)22(34)14-5-3-4-6-14;1-2-32-18(13-4-5-15(25-10-13)21(22,23)24)29-16-17(26-12-27-19(16)32)28-14-6-9-31(11-14)20(33)30-7-3-8-30;1-4-30-19(14-7-22-13(2)23-8-14)27-17-18(24-12-25-20(17)30)26-15-5-6-28(9-15)21(31)29-10-16(11-29)32-3;1-3-26-15-12(23-16(26)13(18)19)14(20-9-21-15)22-10-4-5-24(6-10)17(27)25-7-11(8-25)28-2/h4-5,10,12,14-16H,3,6-9,11H2,1-2H3,(H,28,29,30);7-8,11,13-14,16H,2-6,9-10,12H2,1H3,(H,28,29,30);4-5,10,12,14H,2-3,6-9,11H2,1H3,(H,26,27,28);7-8,12,15-16H,4-6,9-11H2,1-3H3,(H,24,25,26);9-11,13H,3-8H2,1-2H3,(H,20,21,22)/t14?,15-,16?;16-;14-;15-;10-/m00000/s1
InChIKeyMUWBZJNQCPMXTR-KFOHKXHASA-N
XLogP14.00
TPSA481.56 Ų
H-Bond Donors5
H-Bond Acceptors38
Rotatable Bonds25
Heavy Atoms162
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002256.39
LogP ≤ 514.00
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1038

Analyze azetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of azetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone?
The IUPAC name of azetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone (CID 159678068) is azetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone.
What is the SMILES notation for azetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone?
The canonical SMILES for azetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone is CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(N[C@H]3CCN(C(=O)C4CC(OC)C4)C3)ncnc21.CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(N[C@H]3CCN(C(=O)C4CCCC4)C3)ncnc21.CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(N[C@H]3CCN(C(=O)N4CCC4)C3)ncnc21.CCn1c(-c2cnc(C)nc2)nc2c(N[C@H]3CCN(C(=O)N4CC(OC)C4)C3)ncnc21.CCn1c(C(F)F)nc2c(N[C@H]3CCN(C(=O)N4CC(OC)C4)C3)ncnc21.
What is the InChIKey of azetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone?
The InChIKey is MUWBZJNQCPMXTR-KFOHKXHASA-N. The full InChI is InChI=1S/C23H26F3N7O2.C23H26F3N7O.C21H23F3N8O.C21H27N9O2.C17H23F2N7O2/c1-3-33-20(13-4-5-17(27-10-13)23(24,25)26)31-18-19(28-12-29-21(18)33)30-15-6-7-32(11-15)22(34)14-8-16(9-14)35-2;1-2-33-20(15-7-8-17(27-11-15)23(24,25)26)31-18-19(28-13-29-21(18)33)30-16-9-10-32(12-16)22(34)14-5-3-4-6-14;1-2-32-18(13-4-5-15(25-10-13)21(22,23)24)29-16-17(26-12-27-19(16)32)28-14-6-9-31(11-14)20(33)30-7-3-8-30;1-4-30-19(14-7-22-13(2)23-8-14)27-17-18(24-12-25-20(17)30)26-15-5-6-28(9-15)21(31)29-10-16(11-29)32-3;1-3-26-15-12(23-16(26)13(18)19)14(20-9-21-15)22-10-4-5-24(6-10)17(27)25-7-11(8-25)28-2/h4-5,10,12,14-16H,3,6-9,11H2,1-2H3,(H,28,29,30);7-8,11,13-14,16H,2-6,9-10,12H2,1H3,(H,28,29,30);4-5,10,12,14H,2-3,6-9,11H2,1H3,(H,26,27,28);7-8,12,15-16H,4-6,9-11H2,1-3H3,(H,24,25,26);9-11,13H,3-8H2,1-2H3,(H,20,21,22)/t14?,15-,16?;16-;14-;15-;10-/m00000/s1.
What are the key properties of azetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone?
azetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone has a molecular weight of 2256.39 g/mol, XLogP of 14.00, 25 rotatable bonds, 5 hydrogen bond donors, and 38 hydrogen bond acceptors.
Where does this data come from?
All data for azetidin-1-yl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;cyclopentyl-[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]methanone;[(3S)-3-[[8-(difluoromethyl)-9-ethylpurin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-(2-methylpyrimidin-5-yl)purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone;[(3S)-3-[[9-ethyl-8-[6-(trifluoromethyl)-3-pyridinyl]purin-6-yl]amino]pyrrolidin-1-yl]-(3-methoxycyclobutyl)methanone is sourced from PubChem (CID 159678068), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).